Intravenous Anisoylated Plasminogen Streptokinase Activator Complex versus Intravenous Streptokinase in Evolving Myocardial Infarction
- 1 January 1987
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 33 (3), 140-145
- https://doi.org/10.2165/00003495-198700333-00023
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).1986
- Systemic effects of BRL 26921 during thrombolytic treatment of acute myocardial infarctionThrombosis Research, 1985
- On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921)Thrombosis Research, 1981
- Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapyNature, 1981